468 related articles for article (PubMed ID: 33271839)
1. Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity.
Finetti F; Travelli C; Ercoli J; Colombo G; Buoso E; Trabalzini L
Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33271839
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy.
Finetti F; Paradisi L; Bernardi C; Pannini M; Trabalzini L
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190301
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
Take Y; Koizumi S; Nagahisa A
Front Immunol; 2020; 11():324. PubMed ID: 32210957
[TBL] [Abstract][Full Text] [Related]
5. Intracrine prostaglandin E
Madrigal-Martínez A; Fernández-Martínez AB; Lucio Cazaña FJ
J Cell Physiol; 2018 Apr; 233(4):3590-3602. PubMed ID: 29154474
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways.
Echizen K; Hirose O; Maeda Y; Oshima M
Cancer Sci; 2016 Apr; 107(4):391-7. PubMed ID: 27079437
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
Front Immunol; 2018; 9():1859. PubMed ID: 30140269
[TBL] [Abstract][Full Text] [Related]
8. Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis.
Inada M; Takita M; Yokoyama S; Watanabe K; Tominari T; Matsumoto C; Hirata M; Maru Y; Maruyama T; Sugimoto Y; Narumiya S; Uematsu S; Akira S; Murphy G; Nagase H; Miyaura C
J Biol Chem; 2015 Dec; 290(50):29781-93. PubMed ID: 26475855
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma.
Chen C; Guan J; Gu X; Chu Q; Zhu H
Front Cell Dev Biol; 2022; 10():834859. PubMed ID: 35356289
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-Prostaglandin E2 pathway: A key player in tumor-associated immune cells.
Jin K; Qian C; Lin J; Liu B
Front Oncol; 2023; 13():1099811. PubMed ID: 36776289
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor transactivation by intracellular prostaglandin E2-activated prostaglandin E2 receptors. Role in retinoic acid receptor-β up-regulation.
Fernández-Martínez AB; Lucio Cazaña FJ
Biochim Biophys Acta; 2013 Sep; 1833(9):2029-38. PubMed ID: 23644172
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
14. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer.
Mizuno R; Kawada K; Sakai Y
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835815
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E
Aoki T; Narumiya S
Inflamm Regen; 2017; 37():4. PubMed ID: 29259703
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 stimulates normal bronchial epithelial cell growth through induction of c-Jun and PDK1, a kinase implicated in oncogenesis.
Fan Y; Wang Y; Wang K
Respir Res; 2015 Dec; 16():149. PubMed ID: 26684827
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.
De Paz Linares GA; Opperman RM; Majumder M; Lala PK
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668160
[TBL] [Abstract][Full Text] [Related]
19. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
Lala PK; Nandi P; Majumder M
Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
[TBL] [Abstract][Full Text] [Related]
20. Interplay between inflammation and cancer.
Piotrowski I; Kulcenty K; Suchorska W
Rep Pract Oncol Radiother; 2020; 25(3):422-427. PubMed ID: 32372882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
